PRIVISCL Privi Speciality Chemicals Q2 FY26 results (Jul–Sep 2025) and concall
Privi Speciality Chemicals reported a robust Q2 and H1 FY26, achieving record-high revenues and EBITDA margins driven by strong volume growth and new product contributions. The company demonstrated improved operational efficiency, reduced net debt, and enhanced its working capital cycle. Strategic initiatives include capacity expansion, product diversification, and a strong commitment to sustainability, further solidifying its market position.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q2 FY26: revenue up 26.6%, net profit up 112.8% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|
| Revenue | 518 | 498 | 581 | 566 | 656 +27% |
| EBITDA | 111 | 111 | 127 | 136 | 184 +66% |
| Net profit | 47 | 44 | 66 | 69 | 100 +113% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
